TIFFANY STEELMAN: Open Payments
NPI 1073783130 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,073 in 197 payments from 20 companies in 2025. Trend: 2023 $4,193 · 2024 $5,061 · 2025 $4,073
Food & beverage: $4,073
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 56 | $826 |
| Amgen Inc. | 28 | $702 |
| UCB, Inc. | 19 | $467 |
| PFIZER INC. | 15 | $317 |
| GENZYME CORPORATION | 6 | $274 |
| AstraZeneca Pharmaceuticals LP | 12 | $273 |
| Janssen Biotech, Inc. | 11 | $262 |
| Novartis Pharmaceuticals Corporation | 17 | $227 |
| GlaxoSmithKline, LLC. | 8 | $148 |
| E.R. Squibb & Sons, L.L.C. | 5 | $109 |
Products named: RINVOQ, Bimzelx, KEVZARA, SAPHNELO, TAVNEOS, TREMFYA, XELJANZ, COSENTYX.
Industry payments across TN — which companies pay providers there.
